Prognostic effects of arterial carbon dioxide levels in patients hospitalized into the cardiac intensive care unit for acute heart failure.


Journal

European heart journal. Acute cardiovascular care
ISSN: 2048-8734
Titre abrégé: Eur Heart J Acute Cardiovasc Care
Pays: England
ID NLM: 101591369

Informations de publication

Date de publication:
30 Jun 2021
Historique:
received: 26 08 2020
revised: 12 11 2020
accepted: 06 01 2021
entrez: 30 6 2021
pubmed: 1 7 2021
medline: 26 10 2021
Statut: ppublish

Résumé

Although both hypercapnia and hypocapnia are common in acute heart failure (AHF) patients, routine assessment of arterial blood gas is not recommended. Additionally, no association between hypercapnia and increased mortality has been found, and the prognostic value of hypocapnia in AHF patients remains to be elucidated. In this observational study, we aimed to investigate the relationship between partial pressure of arterial carbon dioxide (PaCO2), especially low PaCO2, and long-term mortality in AHF patients. Acute heart failure patients hospitalized in the cardiac intensive care unit of our institution between 2007 and 2011 were screened. All eligible patients were divided into two groups based on the inflection point (i.e. 31.0 mmHg) of the 3-knot cubic spline curve of the hazard ratio (HR), with a PaCO2 of 40 mmHg as a reference. The association between PaCO2 levels and all-cause mortality was assessed using Cox proportional hazards regression models. Among 435 patients with a median follow-up of 1.8 years, 115 (26.4%) died. Adjusted analysis with relevant variables as confounders indicated that PaCO2 <31 mmHg was significantly associated with increased all-cause mortality [HR 1.71, 95% confidence interval (CI) 1.05-2.79; P = 0.032]. When PaCO2 was considered as a continuous variable, the lower was the log-transformed PaCO2, the greater was the increased risk of mortality (HR 0.71, 95% CI 0.52-0.96; P = 0.024). In AHF patients, lower PaCO2 at admission was associated with increased long-term mortality risk.

Identifiants

pubmed: 34192746
pii: 6118427
doi: 10.1093/ehjacc/zuab001
pmc: PMC8245141
doi:

Substances chimiques

Carbon Dioxide 142M471B3J

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

497-502

Subventions

Organisme : Grant-in-Aid for Scientific Research
ID : 26507010
Organisme : JSPS KAKENHI
ID : 17K09527
Organisme : Intractable Respiratory Diseases and Pulmonary Hypertension Research Group
Organisme : Ministry of Health, Labour and Welfare
ID : H29-027
Organisme : MEXT∗-Supported Program for the Strategic Research Foundation at Private Universities
Organisme : Ministry of Education, Culture, Sports, Science and Technology

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Références

Stroke. 1999 Apr;30(4):851-3; discussion 854
pubmed: 10187890
Eur J Intern Med. 2011 Oct;22(5):489-94
pubmed: 21925058
Acta Physiol (Oxf). 2008 Jul;193(3):303-8
pubmed: 18284656
J Neurosurg. 1991 Nov;75(5):731-9
pubmed: 1919695
Pulm Pharmacol Ther. 2007;20(2):130-4
pubmed: 16702004
Thorax. 2009 Oct;64 Suppl 3:iii1-55
pubmed: 19783532
Chest. 2012 Nov;142(5):1193-1199
pubmed: 22677348
J Exp Med. 1929 Mar 31;49(4):531-7
pubmed: 19869562
Circulation. 1999 Mar 30;99(12):1574-9
pubmed: 10096933
Respiration. 2004 Nov-Dec;71(6):657
pubmed: 15627883
Circulation. 2013 May 28;127(21):2107-13
pubmed: 23613256
Crit Care. 2010;14(2):220
pubmed: 20497620
Am Heart J. 2005 Feb;149(2):209-16
pubmed: 15846257
J Am Coll Cardiol. 1986 Nov;8(5):1175-81
pubmed: 3093553
ESC Heart Fail. 2015 Mar;2(1):12-19
pubmed: 28834643
N Engl J Med. 2002 Jul 4;347(1):43-53
pubmed: 12097540
J Am Coll Cardiol. 2013 Jan 29;61(4):391-403
pubmed: 23219302
Eur J Heart Fail. 2008 Oct;10(10):933-89
pubmed: 18826876
J Am Coll Cardiol. 2013 Mar 19;61(11):1157-66
pubmed: 23375931
Am J Respir Crit Care Med. 2017 Mar 1;195(5):557-582
pubmed: 28128970
Am J Kidney Dis. 2009 Jun;53(6):982-92
pubmed: 19339088

Auteurs

Takao Kato (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.

Takatoshi Kasai (T)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Cardiovascular Management and Remote Monitoring, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Digital Health and Telemedicine R&D, Juntendo University Faculty of Health Science, Tokyo, Japan.

Shoko Suda (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.

Akihiro Sato (A)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Sayaki Ishiwata (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Shoichiro Yatsu (S)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Hiroki Matsumoto (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Jun Shitara (J)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Megumi Shimizu (M)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Azusa Murata (A)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Nobuyuki Kagiyama (N)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Digital Health and Telemedicine R&D, Juntendo University Faculty of Health Science, Tokyo, Japan.

Masaru Hiki (M)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Yuya Matsue (Y)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Ryo Naito (R)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Sleep and Sleep-Disordered Breathing Center, Juntendo University Hospital, Tokyo, Japan.
Cardiovascular Respiratory Sleep Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Atsutoshi Takagi (A)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Hiroyuki Daida (H)

Department of Cardiovascular Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Department of Digital Health and Telemedicine R&D, Juntendo University Faculty of Health Science, Tokyo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH